Research Article
A Novel Prognostic Model for Acute Myeloid Leukemia Based on Gene Set Variation Analysis
Table 1
Analysis of clinical characteristics in three subtypes.
| | | Subgroup 1 | Subgroup 2 | Subgroup 3 | P |
| | Age (years), n (%) | | ≤65 | 12 (50) | 33 (91.67) | 42 (64.62) | 0.0012 | | >65 | 12 (50) | 3 (8.33) | 23 (35.38) | | | Gender, n (%) | | Female | 9 (37.5) | 17 (47.22) | 29 (44.62) | 0.7508 | | Male | 15 (62.5) | 19 (52.78) | 36 (55.38) | | | Race, n (%) | | Asian | 0 (0.0) | 0 (0.0) | 1 (1.54) | 0.5978 | | Black or African American | 1 (4.17) | 1 (2.86) | 6 (9.23) | | | White | 23 (95.83) | 34 (97.14) | 58 (89.23) | | | Cytogenetics, n (%) | | Favorable | 1 (4.17) | 5 (13.89) | 11 (17.19) | | | Intermediate | 16 (66.67) | 22 (61.11) | 37 (57.81) | | | Poor | 6 (25) | 9 (25) | 16 (25) | | | Unknown | 1 (4.17) | 0 (0.0) | 0 (0.0) | 0.3639 | | Leukocyte (×10^9/L), n (%) | | ≤25 | 11 (45.83) | 18 (50) | 37 (56.92) | 0.5993 | | >25 | 13 (54.17) | 18 (50) | 28 (43.08) | | | FAB subtype, n (%) | | M0 | 0 (0) | 7 (19.44) | 7 (10.77) | 0.0044 | | M1 | 7 (29.17) | 8 (22.22) | 15 (23.08) | | | M2 | 4 (16.67) | 13 (36.11) | 17 (26.15) | | | M4 | 3 (12.5) | 6 (16.67) | 19 (29.23) | | | M5 | 9 (37.5) | 1 (2.78) | 5 (7.69) | | | M6 | 1 (4.17) | 0 (0) | 1 (1.54) | | | M7 | 0 (0) | 0 (0) | 1 (1.54) | | | Not classified | 0 (0) | 1 (2.78) | 0 (0) | |
|
|
FAB, French-American-British.
|
